Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (491-500 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|December 8, 2016
RB Loss Promotes Prostate Cancer MetastasisChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven MalignanciesSteven N Quayle, Natasha Girgis, Dharma R Thapa, et al.
Cancer Research|October 14, 2021
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate CancerRajendra Kumar, Janet Mendonca, Olutosin Owoyemi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World DataLena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working GroupHoward I Scher, Mario Eisenberger, Anthony V D'Amico, et al.
Cancers|September 9, 2022
Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning EvaluationPeng Huang, Peter B Illei, Wilbur Franklin, et al.
European Urology|January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory RevisitedMatthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Pageof 52

Showing results (491-500 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|December 8, 2016
RB Loss Promotes Prostate Cancer MetastasisChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven MalignanciesSteven N Quayle, Natasha Girgis, Dharma R Thapa, et al.
Cancer Research|October 14, 2021
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate CancerRajendra Kumar, Janet Mendonca, Olutosin Owoyemi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World DataLena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working GroupHoward I Scher, Mario Eisenberger, Anthony V D'Amico, et al.
Cancers|September 9, 2022
Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning EvaluationPeng Huang, Peter B Illei, Wilbur Franklin, et al.
European Urology|January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory RevisitedMatthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
Cancer Discovery|March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targetsHimisha Beltran, David S Rickman, Kyung Park, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Pageof 52